Deutsch English Français

Contact

EP3760233

European procedure

Unitary Patent

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3760233

EP3760233 - ONE-POT PREPARATION PROCESS FOR ANTIBODY DRUG CONJUGATE INTERMEDIATE [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 17.05.2024 Database last updated on 03.08.2024
Former	The patent has been granted Status updated on 09.06.2023
Former	Grant of patent is intended Status updated on 01.02.2023
Former	Examination is in progress Status updated on 14.04.2022
Former	Request for examination was made Status updated on 04.12.2020
Former	The international publication has been made Status updated on 27.11.2020
Former	unknown Status updated on 29.06.2020
Most recent event Tooltip	24.05.2024	Lapse of the patent in a contracting state New state(s): CZ, RO, SK	published on 26.06.2024 [2024/26]
Applicant(s)	For all designated states MabPlex International Co., Ltd. No. 60, Beijing Middle Road Yantai Development Zone Yantai District China (Shandong) Pilot Free Trade Zone Shandong 264006 / CN
	[2021/25]
Former [2021/01]	For all designated states Mabplex International, Ltd. No. 60, Beijing Middle Road Economic And Technological Development Zone Yantai, Shandong 264006 / CN
Inventor(s)	01 / YU, Zhaoxing No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone Shandong 264006 / CN
	02 / LI, Xinfang No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone Shandong 264006 / CN
	03 / LAN, Mingchao No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone Shandong 264006 / CN
	04 / MAO, Xinjie No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone Shandong 264006 / CN
	[2021/25]
Former [2021/12]	01 / YU, Zhaoxing No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone 264006 / CN
	02 / LI, Xinfang No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone 264006 / CN
	03 / LAN, Mingchao No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone 264006 / CN
	04 / MAO, Xinjie No. 60, Beijing Middle Road Yantal Development Zone Yantai District, China (Shandong ) Pilot Free Trade Zone 264006 / CN
Former [2021/01]	01 / YU, Zhaoxing No. 60, Beijing Middle Road Economic And Technological Development Zone yantai, Shandong 264006 / CN
	02 / LI, Xinfang No. 60, Beijing Middle Road Economic And Technological Development Zone yantai, Shandong 264006 / CN
	03 / LAN, Mingchao No. 60, Beijing Middle Road Economic And Technological Development Zone yantai, Shandong 264006 / CN
	04 / MAO, Xinjie No. 60, Beijing Middle Road Economic And Technological Development Zone yantai, Shandong 264006 / CN
Representative(s)	De Clercq & Partners Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem / BE
	[2021/01]
Application number, filing date	20733678.5	13.02.2020
	[2021/01]
	WO2020CN74987
Priority number, date	CN201910420868	20.05.2019 Original published format: CN201910420868
	CN201910916200	26.09.2019 Original published format: CN201910916200
	CN201910916510	26.09.2019 Original published format: CN201910916510
	CN201910916508	26.09.2019 Original published format: CN201910916508
	CN201910916198	26.09.2019 Original published format: CN201910916198
	CN201910916470	26.09.2019 Original published format: CN201910916470
	CN201910916242	26.09.2019 Original published format: CN201910916242
	[2021/01]
Filing language	ZH
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2020233174
	Date:	26.11.2020
	Language:	ZH
	[2020/48]
	Type:	A1 Application with search report
	No.:	EP3760233
	Date:	06.01.2021
	Language:	EN
	[2021/01]
	Type:	B1 Patent specification
	No.:	EP3760233
	Date:	12.07.2023
	Language:	EN
	[2023/28]
Search report(s)	International search report - published on:	CN	26.11.2020
	(Supplementary) European search report - dispatched on:	EP	09.07.2021
Classification	IPC:	A61K47/68, A61P35/00	[2021/01]
	CPC:	A61K47/6889 (EP,KR,RU,US); A61K47/65 (KR,RU,US); A61K47/6803 (KR); A61K31/40 (KR); A61K47/6801 (US); A61K47/68031 (EP,RU,US); (+) A61K47/68037 (EP,RU,US); A61K47/6809 (EP); A61P35/00 (EP,KR,RU); A61K45/06 (US); Y02P20/582 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/01]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	KH	Not yet paid
	MA	Not yet paid
	MD	Not yet paid
	TN	Not yet paid
Title	German:	EINTOPFVERFAHREN ZUR HERSTELLUNG EINES ZWISCHENPRODUKTES EINES ANTIKÖRPER-WIRKSTOFF-KONJUGATS	[2021/01]
	English:	ONE-POT PREPARATION PROCESS FOR ANTIBODY DRUG CONJUGATE INTERMEDIATE	[2021/01]
	French:	PROCÉDÉ DE PRÉPARATION MONOTOPE D'UN INTERMÉDIAIRE CONJUGUÉ DE MÉDICAMENT- ANTICORPS	[2021/01]
Entry into regional phase	29.06.2020	Translation filed
	29.06.2020	National basic fee paid
	29.06.2020	Search fee paid
	29.06.2020	Designation fee(s) paid
	29.06.2020	Examination fee paid
Examination procedure	29.06.2020	Examination requested [2021/01]
	25.01.2022	Amendment by applicant (claims and/or description)
	13.04.2022	Despatch of a communication from the examining division (Time limit: M02)
	13.06.2022	Reply to a communication from the examining division
	29.08.2022	Despatch of a communication from the examining division (Time limit: M04)
	13.12.2022	Reply to a communication from the examining division
	02.02.2023	Communication of intention to grant the patent
	02.06.2023	Fee for grant paid
	02.06.2023	Fee for publishing/printing paid
	02.06.2023	Receipt of the translation of the claim(s)
Opposition(s)	15.04.2024	No opposition filed within time limit [2024/25]
Fees paid	Renewal fee
	07.03.2022	Renewal fee patent year 03
	28.02.2023	Renewal fee patent year 04
	Penalty fee
	Additional fee for renewal fee
	28.02.2022	03 M06 Fee paid on 25.03.2022
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CZ	12.07.2023
	ES	12.07.2023
	HR	12.07.2023
	PL	12.07.2023
	RO	12.07.2023
	RS	12.07.2023
	SK	12.07.2023
	SM	12.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
	[2024/23]
Former [2024/20]	ES	12.07.2023
	HR	12.07.2023
	PL	12.07.2023
	RS	12.07.2023
	SM	12.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/10]	ES	12.07.2023
	HR	12.07.2023
	PL	12.07.2023
	RS	12.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/09]	ES	12.07.2023
	NO	12.10.2023
	GR	13.10.2023
	IS	12.11.2023
Former [2024/08]	NO	12.10.2023
	GR	13.10.2023
Documents cited:	Search	[A]CN109200291 (INST MED BIOTECHNOLOGY CAMS)
	International search	[A]WO2007008603 (SEATTLE GENETICS INC [US], et al);
		[A]CN103933575 (SHANGHAI XINLINIAN BIOPHARMACEUTICAL TECHNOLOGY CO LTD);
		[A]CN107427591 (MEDSHINE DISCOVERY INC);
		[A]CN107921030 (RC BIOTECHNOLOGIES INC);
		[A]CN108727498 (SICHUAN BAILI PHARMACEUTICAL CO LTD);
		[A]CN108727499 (SICHUAN BAILI PHARMACEUTICAL CO LTD);
		[PA]CN110507824 (REMEGEN LTD)
	by applicant	CN107427591
		CN107921030

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p